telmisartan has been researched along with Angioedema in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, SS; Bradford, Y; Brown, NJ; Byrd, JB; Kubo, M; McCarty, CA; Nakamura, Y; Pare, G; Ritchie, M; Ross, S; Teo, KK; Woodard-Grice, A; Zuvich, RL | 1 |
| Bangalore, S; Messerli, FH; Ram, VS | 1 |
| Düsing, R; Nitschmann, S | 1 |
| Anderson, C; Copland, I; Dagenais, G; Dyal, L; Pogue, J; Schumacher, H; Sleight, P; Teo, K; Yusuf, S | 1 |
| DeZee, KJ; Haymore, BR | 1 |
| Guirguis-Blake, J | 1 |
| Borazan, A; Ustün, H; Yilmaz, A | 1 |
| Anderson, C; Copland, I; Dagenais, G; Dyal, L; Pogue, J; Schumacher, H; Sleight, P; Teo, KK; Yusuf, S | 1 |
| Frishman, WH; Guthrie, G; Neutel, JM; Oparil, S; Papademitriou, V | 1 |
| Vidt, DG | 1 |
| Howes, LG; Tran, D | 1 |
2 review(s) available for telmisartan and Angioedema
| Article | Year |
|---|---|
Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Cough; Dizziness; Drug Therapy, Combination; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Patient Readmission; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Telmisartan | 2012 |
Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?
Topics: Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Humans; Irbesartan; Losartan; Telmisartan; Tetrazoles | 2002 |
4 trial(s) available for telmisartan and Angioedema
| Article | Year |
|---|---|
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Black or African American; Double-Blind Method; Drug Therapy, Combination; ETS Translocation Variant 6 Protein; Genome-Wide Association Study; Humans; Isoenzymes; Neprilysin; Polymorphism, Single Nucleotide; Protein Kinase C; Protein Kinase C-theta; Proto-Oncogene Proteins c-ets; Ramipril; Repressor Proteins; Telmisartan; White People | 2013 |
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cough; Female; Follow-Up Studies; Humans; Hypotension; Kaplan-Meier Estimate; Male; Risk Reduction Behavior; Single-Blind Method; Telmisartan; Therapeutic Equivalency | 2008 |
Telmisartan, ramipril, or both in patients at high risk for vascular events.
Topics: Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ramipril; Risk; Telmisartan | 2008 |
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cough; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Patient Dropouts; Telmisartan; Time Factors | 1999 |
5 other study(ies) available for telmisartan and Angioedema
| Article | Year |
|---|---|
Telmisartan, ramipril, or both in patients at high risk of vascular events.
Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypotension; Ramipril; Telmisartan | 2008 |
[ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ].
Topics: Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypotension; Ramipril; Risk Assessment; Risk Factors; Telmisartan | 2008 |
Use of angiotensin receptor blockers after angioedema with an angiotensin-converting enzyme inhibitor.
Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Drug Hypersensitivity; Female; Humans; Male; Meta-Analysis as Topic; Risk; Telmisartan | 2009 |
Angioedema induced by angiotensin II blocker telmisartan.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Telmisartan | 2003 |
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Topics: Acrylates; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Black or African American; Clinical Trials as Topic; Cough; Female; Humans; Imidazoles; Irbesartan; Losartan; Male; Randomized Controlled Trials as Topic; Sex Factors; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2001 |